Sangamo Therapeutics (SGMO) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Financial Fact:
Basic and diluted net loss per share: -0.27
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Basic and diluted net loss per share: -0.27
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q2 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $21.4 million versus the consensus estimate of $21.43 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Sangamo picks Lilly and PTC as buyers in bankruptcy auction
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
